Speakers - Next Generation Dx Summit 2010

Mara Aspinall, President and CEO, On-Q-ity

Finley Austin, Ph.D., US Head, External Research and Innovation Environment, Roche Discovery Technologies

Vickie Baselski, Ph.D., D(ABMM), FAAM, Professor, Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center

Keith F. Batchelder, CEO, Genomic Healthcare Strategies

Holger Becker, Ph.D., CSO, microfluidic ChipShop

Michel G. Bergeron, O.Q., M.D., FRCPC, FCAHS, Professor, Director and Founder, Centre de Recherche en Infectiologie (CRI) de l’Université Laval

Robert Bonomo, M.D., Associate Professor of Medicine; Director, Cleveland VAMC GRECC

Christoph Borchers, Ph.D., Associate Professor and Director, Biochemistry and Microbiology, University of Victoria, UVic Genome BC Proteomics Centre

Thomas Briese, Ph.D., Associate Professor of Clinical Epidemiology, Center for Infection and Immunity, Mailman School of Public Health, Columbia University

Steven Buchsbaum, Ph.D., Senior Program Officer, Global Health Technologies, Bill & Melinda Gates Foundation

John C. Carrano, Ph.D., President, Carrano Consulting, LLC

Philip Castle, Ph.D., Senior Investigator, Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, NIH, DHHS

Anita J. Chawla, Ph.D., Vice President, Analysis Group

Shuqi Chen, Ph.D., Chief Executive Officer, IQuum, Inc.

George Church, Ph.D., Co-Founder, Pathogenica; Professor of Genetics, Harvard Medical School

Yolanda A. Cillo, M.D., M.B.A., Medical Director, Abbott Point of Care

Franklin R. Cockerill, III, M.D., Ann and Leo Markin Professor of Microbiology & Medicine; Chair, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine; President and CEO, Mayo Medical Laboratories and Mayo Collaborative Services, Inc.

William Cook, MBA, Principal, Strategy and Business Development, Clinical Diagnostics, WECA

Robert W. Coombs, M.D., Ph.D., Professor & Vice-Chair for Research, Department of Laboratory Medicine, Director, University of Washington Retrovirology Laboratory

Mark Carle Connelly, Ph.D., Director, Cellular Research, Veridex, LLC

Chad Creighton, Ph.D., Assistant Professor, Division of Biostatistics, Dan L. Duncan Cancer Center, Baylor College of Medicine

Robert Dunstan, Ph.D., Distinguished Investigator, PCDS, Biogen Idec

Brian T. Edmonds, Ph.D., Research Advisor, Global External Research & Development, Lilly Corporate Center

Garth D. Ehrlich, Ph.D., Professor of Microbiology and Immunology, Drexel University College of Medicine; Executive Director, Center for Genomic Sciences, Allegheny Singer Research Institute

Tomi Erho, Senior Research Scientist, VTT Technical Research Centre of Finland

Kelly Feist, Vice President, Sunquest Information Systems

Tamara Feldblyum, Scientific Reviewer, Division of Microbiology Devices, FDA/CDRH/OIVD

Brad Foulk, Veridex, LLC

Felix W. Frueh, Ph.D., Vice President, Research & Development & Personalized Medicine, Medco Health Solutions, Inc.

Cynthia Gawron-Burke, Ph.D., External Scientific Affairs, Merck Research Laboratories

Christine C. Ginocchio, Ph.D., M.T. (A.S.C.P.), Senior Director, Division of Infectious Disease Diagnostics, North Shore-LIJ Health System Laboratories; Associate Professor, Pathology and Laboratory Medicine and Molecular Medicine, Hofstra University School of Medicine in collaboration with the North Shore-LIJ Health System

Harry Glorikian, Managing Partner, Scientia Advisors

Steve Gutman, Ph.D., Technology Evaluation Center, Associate Director, Blue Cross and Blue Shield Association

Manzour H. Hazbón, Ph.D., Senior Scientist, Meso-Scale Diagnostics

Marcia J. Holden, Ph.D., Research Biologist, Biochemical Science Division, National Institute of Standards and Technology

Kattesh Katti, Ph.D., Professor of Radiology; Director, Cancer Nanotechnology Platform, Radiology, University of Missouri

Peter Keeling, Chief Executive Officer, Diaceutics

Moon-Soo Kim, Ph.D., Post-Doc, Genome Center and Department of Pharmacology, UC Davis

Michael J. Kozal, M.D., Associate Professor of Medicine, Yale University School of Medicine; Chief, Section of Infectious Diseases, VA CT Healthcare System6:30

Myla Lai-Goldman, M.D., CEO, CancerGuide Diagnostics, Inc.

Andrea H. Lauber, Ph.D., Head, Technology Transactions for Clinical Biomarkers & Pharmacodiagnostics Strategic Transactions Group, Bristol-Myers Squibb

Rebecca Leary, Ph.D., Post Doctoral Fellow, Oncology, Ludwig Center for Cancer Genetics and Therapeutics, The Johns Hopkins Kimmel Cancer Center

Hans Lehrach, Ph.D., Director, Max Planck Institute for Molecular Genetics, Berlin; Head, Department of Vertebrate Genomics

Jorge A. León, Ph.D., President, Leomics Consulting

Stephen Little, Ph.D., Vice President, Personalized Healthcare, QIAGEN (Formerly CEO, DxS Ltd.)

Matthew Lorence, Ph.D., M.B.A., Vice President, Marketing and Sales, Tessarae, LLC

Mirella Marlow, M.B.A., Programme Director – Devices and Diagnostic Systems, Centre for Health Technology Evaluation, National Institute for Health and Clinical Excellence

Francisco Martinez-Murillo, Ph.D., Staff Fellow, Food & Drug Administration

Daniel R. McClernon, McClernon, LLC

John McDonald, Ph.D., Professor and Director, Integrated Cancer Research Center, School of Biology, Georgia Institute of Technology

Peter S. Miller, COO, Genomic Healthcare Strategies

Kasinathan Muralidharan, Ph.D., Senior Director, Molecular Genetics, Quest Diagnostics Nichols Institute

Patrick R. Murray, Ph.D., Chief and Senior Scientist, Clinical Microbiology Laboratory, NIH Clinical Center

Stephen Naylor, Ph.D., CEO and Chairman, Predictive Physiology & Medicine Inc.

Robin Patel, M.D.(CM), FRCP(C), (D)ABMM, FACP, Consultant, Divisions of Clinical, Microbiology and Infectious Diseases, Professor of Microbiology and Medicine, College of Medicine, Mayo Clinic

Gary Palmer, CMO, On-Q-ity

Charles Paulding, Ph.D., Senior Group Head, Pharmacogenetic Analysis, Biomarker Development Novartis Institutes for BioMedical Research

Cathy A. Petti, M.D., Associate Professor (Adjunct) of Medicine, Stanford University Medical Center

Munir Pirmohamed, MB, ChB (Hons), Ph.D., FRCP, FRCP(E), Professor, The Wolfson Centre for Personalised Medicine, Department of Pharmacology, University of Liverpool

Michael G. Pollack, Ph.D., Co-Founder, Advanced Liquid Logic, Inc.

Christopher Price, Ph.D., Visiting Professor in Clinical Biochemistry, Oxford University

Gary W. Procop, M.D., M.S., Chair, Department of Molecular Pathology; Section Head, Molecular Microbiology; Director, Mycology, and Parasitology; Professor of Pathology, Cleveland Clinic

Bruce Quinn, M.D., Ph.D., Senior Health Policy Specialist, Foley Hoag LLP

Charlie Raffin, CJR Advisors, LLC (formerly Vice President, Commercial Assessment, J&J)

Chandra Rao, Ph.D., Manager, CellSearch Reagent Development, Veridex, LLC

Avraham Rasooly, Ph.D., Program Director, Cancer Diagnosis Program, National Cancer Institute

Jason Rolland, Ph.D., Director of Research, Diagnostics For All Inc.

Jeffrey S. Ross, M.D., Cyrus Strong Merrill Professor & Chair, Department of Pathology & Laboratory Medicine, Albany Medical College and Foundation Medicine

Hakan Sakul, Ph.D., Senior Director and Global Head, Diagnostics and Oncology Leads, Molecular Medicine Group, Pfizer Global R&D

Ginette Serrero, Ph.D., CEO, Oncology Biomarker, A&G Pharmaceutical, Inc.

Wei Shen, Ph.D., Associate Professor, Australian Pulp and Paper Institute, Department of Chemical Engineering, Monash University

Henriette Skribek, Ph.D., Researcher, Microbiology, Tumor and Cell Biology, Karolinska Institute

K. Stephen Suh, Ph.D., Scientific Director, Tissue Bank, Cancer Research Program, The John Theurer Cancer Center, Hackensack University Medical Center

Jeffery K. Taubenberger, M.D., Ph.D., Chief, Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National  Institutes of Health

Patrick Terry, CEO, Applied Clinical Genomics, Technic Solutions, LLC

Peter Tolias, Ph.D., Executive Director, Institute of Genomic Medicine; Research Director, The Autism Center; Professor, Department of Pediatrics, UMDNJ New Jersey Medical School

David Wang, Ph.D., Departments of Molecular Microbiology and Pathology and Immunology, Washington University in St. Louis

Alexander L. Weis, Ph.D., FRSC, CEO, OncoVista, Inc.; Managing Director, AdnaGen AG; Adjunct Professor, University of Texas Health Science Center, San Antonio 

Stephen A. Williams, M.D., Ph.D., CMO, SomaLogic, Inc.

Henrik Winther, Ph.D., Research & Development Director, ImmunoHistology and IHC PharmDx, Dako Denmark A/S

Donna M. Wolk, Ph.D., D(ABMM), Associate Research Professor, BIO5 Institute, Division Chief for Clinical and Molecular Microbiology, Department of Pathology, Arizona Health Science Center and University Medical Center

Robert E. Yocher, M.H.Sc., RAC, FRAPS, Vice President, Regulatory Affairs and Corporate Quality Compliance, Genzyme Corporation